Advanced Upper GI Cancer Session 2 — ASN Events

Advanced Upper GI Cancer Session 2 — ASN Events

Advanced Upper GI Cancer Session 2

Management of Peritoneal Carcinomatosis (10467)

Richard Goldberg

INDIVIDUALISED MOLECULAR PANCREATIC CANCER THERAPY (IMPaCT): A randomised, open label, phase II trial assessing standard first line treatment with gemcitabine or personalised treatment based on tumour molecular signature in patients with recurrent or metastatic pancreatic cancer to evaluate feasibility and impact on progression free survival (10533)

Lorraine Chantrill

LAP07: Randomised multicentre phase III study in participants with locally advanced adenocarcinoma of the pancreas: gemcitabine with or without chemoradiotherapy and with or without erlotinib. (10534)

David Goldstein

A randomised phase II trial of imatinib alternating with regorafenib compared to imatinib alone for the first line treatment of advanced gastrointestinal stromal tumour (GIST) (10535)